Octave Specialty Group heads into its third-quarter report with a split personality. Its insurance distribution business is growing so fast that management lifted both its organic growth and profit targets last quarter. At the same time, the company slashed its consolidated adjusted earnings outlook and trimmed expectations for Everspan, its underwriting arm. The November 9 release, due after the close, is the first real chance to see which of those two stories carries more weight as the year winds down.
Wall Street is looking for an adjusted loss of 6 cents a share on revenue of about $83.1 million. That is essentially flat with the $83.0 million the company booked last quarter and a slightly wider loss than the 4 cents it posted then. The flat revenue estimate is the first thing worth questioning. A business that just raised its distribution organic growth target to at least 25%, up from 20% earlier in the year, would not normally be expected to stall sequentially. If revenue comes in meaningfully above consensus, it would suggest the newer managing general agents are still scaling as quickly as management claimed. A number at or below the estimate would invite questions about whether the softening property market is starting to bite.
The distribution segment is the center of the bull case. Second-quarter revenue there rose 77%, with 44% organic growth, and segment adjusted EBITDA nearly quadrupled to $9.8 million as margins widened to 16.8% from 7.6% a year earlier. Management now expects about $45 million in full-year distribution EBITDA, up from $40 million. Validating that guidance requires continued margin expansion this quarter, not just top-line growth. Management also credited the 2024 and 2025 classes of MGAs, roughly 40% of the portfolio, with about three-quarters of organic growth, noting that around half are already EBITDA-positive. Evidence that more of those businesses have crossed into profitability would strengthen the long-term path toward the company's $80 million 2028 EBITDA target.
Everspan is the swing factor. Underwriting improved sharply last quarter, with the combined ratio falling to 100.6% from 106.7% and the loss ratio dropping 640 basis points. Yet full-year EBITDA guidance was cut to $6 million from $7.5 million because newer programs carry higher acquisition costs. Investors should look for whether the combined ratio can hold near or below 100%, and whether premium growth toward the roughly $410 million full-year goal is starting to dilute fixed costs. Early commentary on the Cytora AI underwriting platform, which management says cuts quoting time from hours to about seven minutes, and its planned rollout across U.S. MGAs in the second half, would add color on whether technology can offset pricing pressure. Wholesale large property rates were down 10% to 20%, with weakness in energy and difference-in-conditions property, so any sign of that spreading would challenge the narrative.
The mood has thawed considerably. Sentiment ahead of this report is roughly neutral, a marked improvement from the decidedly bearish reading before the last release. The stock has slipped 1.4% since then, a hair better than the broader market. At $5.04 it sits below its 200-day moving average of $5.22 and well beneath last quarter's trading range, though it has recovered from a post-earnings low near $3.99. In other words, the guidance reset appears largely absorbed, but enthusiasm has not returned.
The central question is whether management can reaffirm its $0.15 to $0.20 full-year adjusted EPS outlook, which would mark the first positive adjusted year since the specialty strategy began in 2021. Another quarterly loss leaves less room for error in the final quarter. If distribution margins keep climbing and Everspan avoids another cut, the earlier reset will look like conservative housekeeping. If not, the story of a profitable inflection gets pushed further out.